Myocardial protection in the acutely injured heart: Hyperpolarizing versus depolarizing hypothermic cardioplegia

Jennifer Lawton, P. W. Hsia, C. T. Allen, Jr Damiano

Research output: Contribution to journalArticle

Abstract

Objectives: The superiority of hyperpolarized arrest with adenosine triphosphate-sensitive potassium channel openers over standard hyperkalemic depolarizing cardioplegia during normothermic ischemia has been documented. This study examined the hypothesis that pinacidil would provide superior protection in a more clinically relevant model of an acutely injured heart and hypothermic cardioplegic arrest. Methods: In a blood-perfused, parabiotic, rabbit heart Langendorff model, hearts underwent 15 minutes of unprotected global normothermic ischemia before the administration of 50 ml of cardioplegic solution at 4°C, followed by 50 minutes of hypothermic (15°C) ischemia and 30 minutes of reperfusion. The cardioplegic solutions administered consisted of Krebs-Henseleit solution alone (N = 6), Krebs- Henseleit solution with pinacidil (50 μmol/L; N = 10), Krehs-Henseleit solution with pinacidil (50 μmol/L) and glibenclamide (a potassium channel blocker, 10 μmol/L; N = 8), or St. Thomas' Hospital solution (N = 8). The percent recovery of developed pressure, linear diastolic pressure-volume relationships, and coronary blood flow were compared. Results: The percent recovery of developed pressure was 32.8% ± 2.8%, 43.0% ± 4.3%, 46.5% ± 2.2%, and 49.3% ± 2.7% for the Krebs-Henseleit, the Krebs-Henseleit with pinacidil and glibenclamide, the St. Thomas' Hospital, and the Krebs- Henseleit with pinacidil groups, respectively. No hearts had ventricular fibrillation on reperfusion. Conclusions: During hypothermic hyperpolarized arrest, as opposed to normothermic ischemia as in our previous studies, there was neither an increased incidence of ventricular fibrillation nor prolonged electrical activity when compared with results during traditional hyperkalemic arrest. Myocardial protection by St. Thomas' Hospital solution and pinacidil was superior (p = 0.009) to that with Krebs-Henseleit solution alone. The protection provided by pinacidil was lost with the addition of glibenclamide, indicating that the drug has adenosine triphosphate-sensitive potassium channel activity during hypothermia.

Original languageEnglish (US)
Pages (from-to)567-575
Number of pages9
JournalJournal of Thoracic and Cardiovascular Surgery
Volume113
Issue number3
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Pinacidil
Induced Heart Arrest
Glyburide
Ischemia
Cardioplegic Solutions
Potassium Channels
Ventricular Fibrillation
Reperfusion
Adenosine Triphosphate
Potassium Channel Blockers
Pressure
Hypothermia
Rabbits
Blood Pressure
Incidence

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Myocardial protection in the acutely injured heart : Hyperpolarizing versus depolarizing hypothermic cardioplegia. / Lawton, Jennifer; Hsia, P. W.; Allen, C. T.; Damiano, Jr.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 113, No. 3, 1997, p. 567-575.

Research output: Contribution to journalArticle

@article{4b7531a731334759854282554788b4f1,
title = "Myocardial protection in the acutely injured heart: Hyperpolarizing versus depolarizing hypothermic cardioplegia",
abstract = "Objectives: The superiority of hyperpolarized arrest with adenosine triphosphate-sensitive potassium channel openers over standard hyperkalemic depolarizing cardioplegia during normothermic ischemia has been documented. This study examined the hypothesis that pinacidil would provide superior protection in a more clinically relevant model of an acutely injured heart and hypothermic cardioplegic arrest. Methods: In a blood-perfused, parabiotic, rabbit heart Langendorff model, hearts underwent 15 minutes of unprotected global normothermic ischemia before the administration of 50 ml of cardioplegic solution at 4°C, followed by 50 minutes of hypothermic (15°C) ischemia and 30 minutes of reperfusion. The cardioplegic solutions administered consisted of Krebs-Henseleit solution alone (N = 6), Krebs- Henseleit solution with pinacidil (50 μmol/L; N = 10), Krehs-Henseleit solution with pinacidil (50 μmol/L) and glibenclamide (a potassium channel blocker, 10 μmol/L; N = 8), or St. Thomas' Hospital solution (N = 8). The percent recovery of developed pressure, linear diastolic pressure-volume relationships, and coronary blood flow were compared. Results: The percent recovery of developed pressure was 32.8{\%} ± 2.8{\%}, 43.0{\%} ± 4.3{\%}, 46.5{\%} ± 2.2{\%}, and 49.3{\%} ± 2.7{\%} for the Krebs-Henseleit, the Krebs-Henseleit with pinacidil and glibenclamide, the St. Thomas' Hospital, and the Krebs- Henseleit with pinacidil groups, respectively. No hearts had ventricular fibrillation on reperfusion. Conclusions: During hypothermic hyperpolarized arrest, as opposed to normothermic ischemia as in our previous studies, there was neither an increased incidence of ventricular fibrillation nor prolonged electrical activity when compared with results during traditional hyperkalemic arrest. Myocardial protection by St. Thomas' Hospital solution and pinacidil was superior (p = 0.009) to that with Krebs-Henseleit solution alone. The protection provided by pinacidil was lost with the addition of glibenclamide, indicating that the drug has adenosine triphosphate-sensitive potassium channel activity during hypothermia.",
author = "Jennifer Lawton and Hsia, {P. W.} and Allen, {C. T.} and Jr Damiano",
year = "1997",
doi = "10.1016/S0022-5223(97)70372-6",
language = "English (US)",
volume = "113",
pages = "567--575",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Myocardial protection in the acutely injured heart

T2 - Hyperpolarizing versus depolarizing hypothermic cardioplegia

AU - Lawton, Jennifer

AU - Hsia, P. W.

AU - Allen, C. T.

AU - Damiano, Jr

PY - 1997

Y1 - 1997

N2 - Objectives: The superiority of hyperpolarized arrest with adenosine triphosphate-sensitive potassium channel openers over standard hyperkalemic depolarizing cardioplegia during normothermic ischemia has been documented. This study examined the hypothesis that pinacidil would provide superior protection in a more clinically relevant model of an acutely injured heart and hypothermic cardioplegic arrest. Methods: In a blood-perfused, parabiotic, rabbit heart Langendorff model, hearts underwent 15 minutes of unprotected global normothermic ischemia before the administration of 50 ml of cardioplegic solution at 4°C, followed by 50 minutes of hypothermic (15°C) ischemia and 30 minutes of reperfusion. The cardioplegic solutions administered consisted of Krebs-Henseleit solution alone (N = 6), Krebs- Henseleit solution with pinacidil (50 μmol/L; N = 10), Krehs-Henseleit solution with pinacidil (50 μmol/L) and glibenclamide (a potassium channel blocker, 10 μmol/L; N = 8), or St. Thomas' Hospital solution (N = 8). The percent recovery of developed pressure, linear diastolic pressure-volume relationships, and coronary blood flow were compared. Results: The percent recovery of developed pressure was 32.8% ± 2.8%, 43.0% ± 4.3%, 46.5% ± 2.2%, and 49.3% ± 2.7% for the Krebs-Henseleit, the Krebs-Henseleit with pinacidil and glibenclamide, the St. Thomas' Hospital, and the Krebs- Henseleit with pinacidil groups, respectively. No hearts had ventricular fibrillation on reperfusion. Conclusions: During hypothermic hyperpolarized arrest, as opposed to normothermic ischemia as in our previous studies, there was neither an increased incidence of ventricular fibrillation nor prolonged electrical activity when compared with results during traditional hyperkalemic arrest. Myocardial protection by St. Thomas' Hospital solution and pinacidil was superior (p = 0.009) to that with Krebs-Henseleit solution alone. The protection provided by pinacidil was lost with the addition of glibenclamide, indicating that the drug has adenosine triphosphate-sensitive potassium channel activity during hypothermia.

AB - Objectives: The superiority of hyperpolarized arrest with adenosine triphosphate-sensitive potassium channel openers over standard hyperkalemic depolarizing cardioplegia during normothermic ischemia has been documented. This study examined the hypothesis that pinacidil would provide superior protection in a more clinically relevant model of an acutely injured heart and hypothermic cardioplegic arrest. Methods: In a blood-perfused, parabiotic, rabbit heart Langendorff model, hearts underwent 15 minutes of unprotected global normothermic ischemia before the administration of 50 ml of cardioplegic solution at 4°C, followed by 50 minutes of hypothermic (15°C) ischemia and 30 minutes of reperfusion. The cardioplegic solutions administered consisted of Krebs-Henseleit solution alone (N = 6), Krebs- Henseleit solution with pinacidil (50 μmol/L; N = 10), Krehs-Henseleit solution with pinacidil (50 μmol/L) and glibenclamide (a potassium channel blocker, 10 μmol/L; N = 8), or St. Thomas' Hospital solution (N = 8). The percent recovery of developed pressure, linear diastolic pressure-volume relationships, and coronary blood flow were compared. Results: The percent recovery of developed pressure was 32.8% ± 2.8%, 43.0% ± 4.3%, 46.5% ± 2.2%, and 49.3% ± 2.7% for the Krebs-Henseleit, the Krebs-Henseleit with pinacidil and glibenclamide, the St. Thomas' Hospital, and the Krebs- Henseleit with pinacidil groups, respectively. No hearts had ventricular fibrillation on reperfusion. Conclusions: During hypothermic hyperpolarized arrest, as opposed to normothermic ischemia as in our previous studies, there was neither an increased incidence of ventricular fibrillation nor prolonged electrical activity when compared with results during traditional hyperkalemic arrest. Myocardial protection by St. Thomas' Hospital solution and pinacidil was superior (p = 0.009) to that with Krebs-Henseleit solution alone. The protection provided by pinacidil was lost with the addition of glibenclamide, indicating that the drug has adenosine triphosphate-sensitive potassium channel activity during hypothermia.

UR - http://www.scopus.com/inward/record.url?scp=0030939871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030939871&partnerID=8YFLogxK

U2 - 10.1016/S0022-5223(97)70372-6

DO - 10.1016/S0022-5223(97)70372-6

M3 - Article

C2 - 9081104

AN - SCOPUS:0030939871

VL - 113

SP - 567

EP - 575

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 3

ER -